"Spezialklinik für Innere Medizin seit 1946. Wir zeichnen uns durch eine einzigartige Kombination aus modernsten medizinischen Methoden und einer patientenorientierten Behandlungsphilosophie aus. „Im Mittelpunkt unserer Bemühungen steht der kranke Mensch“, so brachte es Dr. Robert Schindlbeck auf den Punkt. Im Laufe des Bestehens wurde die Klinik durch ihre erstklassigen diagnostischen Einrichtungen und die Behandlungserfolge bis weit über die Grenzen Bayerns bekannt. Ob gesetzlich oder privat versichert bei uns sind alle Patienten herzlich willkommen. Unser Ziel ist es, Ihnen medizinische Versorgung aus einer Hand auf höchstem Niveau und in freundlicher Umgebung anbieten zu können."

During the past decade, Privatklinik Dr. R. Schindlbeck GmbH & Co. KG conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are "Lymphoma" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" in a lesser frequency.

Most popular intervention types in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are "Drug" (8 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Privatklinik Dr. R. Schindlbeck GmbH & Co. KG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Privatklinik Dr. R. Schindlbeck GmbH & Co. KG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Privatklinik Dr. R. Schindlbeck GmbH & Co. KG, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".